Search Results - "Dibridge, Julie"
-
1
Reduction of HLA donor specific antibodies in heart transplant patients treated with proteasome inhibitors for antibody mediated rejection
Published in Clinical transplantation (01-12-2023)“…In this project, we describe proteasome inhibitor (PI) treatment of antibody‐mediated rejection (AMR) in heart transplantation (HTX). From January 2018 to…”
Get full text
Journal Article -
2
Comparison of three cisatracurium dosing strategies in acute respiratory distress syndrome: A focus on drug utilization and improvement in oxygenation
Published in Journal of critical care (01-12-2021)“…Three continuous dosing strategies of cisatracurium (CIS) for acute respiratory distress syndrome (ARDS) have been described in the literature. After…”
Get full text
Journal Article -
3
Implementation of a perioperative ketamine shortage mitigation strategy
Published in Korean journal of anesthesiology (01-06-2020)“…KCI Citation Count: 0…”
Get full text
Journal Article -
4
Off-Label Use of Agents for Management of Serious or Life-threatening Angiotensin Converting Enzyme Inhibitor–Induced Angioedema
Published in Annals of Pharmacotherapy (01-01-2016)“…Objective: To evaluate the place in therapy of fresh frozen plasma (FFP), C1 esterase concentrate (C1-INH), ecallantide, and icatibant in the management of…”
Get full text
Book Review Journal Article -
5
841: Comparison of 4-Factor Prothrombin Complex Concentrate Dosing Strategies for Warfarin Reversal
Published in Critical care medicine (01-01-2021)Get full text
Journal Article -
6
49: Evaluation of Dosing Strategies on Cisatracurium on Drug Consumption and Oxygenation
Published in Critical care medicine (01-01-2021)Get full text
Journal Article -
7
CARC12: Novel Purge System Modification Reduces Incidence of Impella 5.5 Dysfunction
Published in ASAIO journal (1992) (01-06-2022)Get full text
Journal Article -
8
Outcomes of systemic bivalirudin and sodium bicarbonate purge solution for Impella 5.5
Published in Artificial organs (01-02-2023)“…Background Impella 5.5 (Abiomed; Danvers, MA) (IMP5) is a commonly used, surgically implanted, tMCS device that requires systemic anticoagulation and purge…”
Get full text
Journal Article -
9
Collaboration between pharmacists in community pharmacy and ambulatory clinic settings: Current state and future directions
Published in JAACP : Journal of the American College of Clinical Pharmacy (01-06-2023)“…Pharmacists in the community and ambulatory settings are primed for collaboration that can optimize care. Now is the time to capitalize on the momentum and…”
Get full text
Journal Article